Nystatin + Neomycin Sulfate + Thiostrepton + Triamcinolone Acetonide
54 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
54
Total Reports
4
Deaths Reported
740.0%
Death Rate
Active Ingredients
Nystatin + Neomycin Sulfate + Thiostrepton + Triamcinolone Acetonide
Administration Routes
UnknownTopicalAuricular (Otic)CutaneousOral
Species Affected
Dog 48
Cat 6
Most Affected Breeds
Retriever - Golden 10
Retriever - Labrador 8
Domestic Shorthair 4
Beagle 2
Shepherd Dog - German 2
Boxer (German Boxer) 2
Spaniel - King Charles Cavalier 2
Greyhound 2
Dog (other) 1
Crossbred Canine/dog 1
Most Reported Reactions
Vomiting 9
Emesis 6
Lethargy (see also Central nervous system depression in 'Neurological') 6
Lack of efficacy - NOS 5
Ear infection NOS 5
Not eating 3
Behavioural disorder NOS 3
Bacterial skin infection NOS 3
Polyuria 3
Decreased appetite 3
Death by euthanasia 3
Lethargy (see also Central nervous system depression in Neurological) 3
Outcome Breakdown
Outcome Unknown
17 (31.5%)
Recovered/Normal
16 (29.6%)
Ongoing
16 (29.6%)
Euthanized
3 (5.6%)
Recovered with Sequela
1 (1.9%)
Died
1 (1.9%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.